Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy


Akyuz F. , Kaymakoglu S. , Demir K. , Aksoy N., Karaca C., Danalioglu A., ...Daha Fazla

Acta Gastro-Enterologica Belgica, cilt.70, ss.20-24, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 70 Konu: 1
  • Basım Tarihi: 2007
  • Dergi Adı: Acta Gastro-Enterologica Belgica
  • Sayfa Sayıları: ss.20-24

Özet

Background and study aims : To investigate the efficacy of the combined therapy of lamivudine (LAM) plus alpha interferon (IFN) and LAM monotherapy in HBeAg negative chronic hepatitis B (CHB) patients who were unresponsive to previous IFN monotherapy, and the incidence of YMDD mutations.